French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

The site will be in the Beijing Economic and Technological Development Zone where Sanofi already has production facilities ...

The challenges of diabetes are real and we live with them every single day. It’s 1:30 am and I’m sitting in Leah’s room. I ...

Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay ...

While weight loss can result in reducing insulin resistance, improving the way you eat can also help to lower your insulin levels. The key is to choose foods that don't raise your insulin even more.

Hongchi Xiao was convicted of manslaughter for failing to get medical help for Danielle Carr-Gomm as she howled in pain and ...

Berson, S. A., and Yalow, R. S., “Adv. in Biol. and Med. Physics”, 6, 350 (1958).

Embecta said Tuesday that it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The Parsippany, New ...

As an employer providing health insurance to its workers who choose to have it, Waukegan Community Unit School District 60 is faced with paying much of the ballooning cost of insulin for those who ...

Current health news highlights include Sanofi's $1 billion investment in a Beijing insulin site, New Zealand's poultry export suspension due to bird flu, the U.S. Supreme Court case on FDA vaping ...